Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Aprepitant

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 15,881Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Inke Achieves Aprepitant CEP and Salmeterol DMF A Step Forward
    Inke Achieves Aprepitant CEP and Salmeterol DMF A Step Forward

    04 Dec 2024

    // PRESS RELEASE

    https://www.inke.es/news/inke-achieves-aprepitant-cep-and-salmeterol-dmf-a-step-forward/

    PRESS RELEASE
    04 Dec 2024
    Share Share
    Anti-Nausea Based Drug Reduces Alzheimer's Astrocytes In Mice
    Anti-Nausea Based Drug Reduces Alzheimer's Astrocytes In Mice

    18 Sep 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/research/drug-based-anti-nausea-agent-reduces-alzheimers-advancing-astrocytes-mice

    FIERCE BIOTECH
    18 Sep 2024
    Share Share
    Nanoform, PlusVitech Partner To Repurpose Aprepitant For Lung Cancer
    Nanoform, PlusVitech Partner To Repurpose Aprepitant For Lung Cancer

    09 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nanoform-and-plusvitech-partner-to-repurpose-aprepitant-as-a-treatment-for-lung-cancer-302111314.html

    PR NEWSWIRE
    09 Apr 2024
    Share Share
    FDA Confirms Paragraph IV Patent Litigation for Aprepitant Intravenous Emulsion
    FDA Confirms Paragraph IV Patent Litigation for Aprepitant Intravenous Emulsion

    10 Jan 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-aprepitant-intravenous-emulsion-43936.pdf

    FDA
    10 Jan 2024
    Share Share
    Heron scores FDA for Aponvie, alternative to pills for postoperative nausea
    Heron scores FDA for Aponvie, alternative to pills for postoperative nausea

    20 Sep 2022

    // Kevin Dunleavy FIERCEPHARMA

    https://www.fiercepharma.com/pharma/heron-scores-fda-go-ahead-aponvie-iv-alternative-pills-postoperative-nausea

    Kevin Dunleavy FIERCEPHARMA
    20 Sep 2022
    Share Share
    FDA Confirms Paragraph IV Patent Litigation for Aprepitant
    FDA Confirms Paragraph IV Patent Litigation for Aprepitant

    13 Jun 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-aprepitant-1655269712.pdf

    FDA
    13 Jun 2022
    Share Share